Variables Affecting Patient Adherence to T2DM Treatment: How Can Pharmacists Improve Outcomes?

Need some CEs? This is a pretty good one.

Ref: 

Jerry Meece, RPh, CDE, FACA, FAADE, Activity Chairman; Susan Cornell, PharmD, CDE, FAPhA, FAADE; David Pope, PharmD, CDM, CDE

Faculty and Disclosures

CE Released: 06/22/2015 ; Valid for credit through 06/22/2016

http://www.medscape.org/viewarticle/844933?src=wnl_cme_revw